SEMA3B: A Potential Drug Target and Biomarker (G7869)
![Review Report on SEMA3B Target / Biomarker](https://silexon.ai/img/target-biomarker-review.jpg?a=1)
![Content of Review Report on SEMA3B Target / Biomarker](https://silexon.ai/img/target-biomarker-review-content.jpg?a=2)
SEMA3B: A Potential Drug Target and Biomarker
Semaphorin 3B (SEMA3B) is a protein that is expressed in various tissues throughout the body. It is a member of the semaphorin family of transmembrane proteins, which are known for their unique structure and function. SEMA3B is characterized by its long N-terminus, which contains a unique glycosylation pattern.
SEMA3B has been shown to play a role in various physiological processes, including cell signaling, embryonic development, and tissue repair. It is involved in the development and maintenance of the nervous system, as well as the regulation of inflammation and immune response.
SEMA3B has also been identified as a potential drug target. Its unique structure and function have led to the development of small molecules that can interact with SEMA3B and modulate its activity. These small molecules have been shown to have a range of therapeutic effects, including the inhibition of cancer growth, the regulation of pain perception, and the modulation of cell signaling pathways.
In addition to its potential as a drug target, SEMA3B has also been identified as a biomarker. Its expression has been shown to be associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The identification of SEMA3B as a biomarker has the potential to aid in the development of new diagnostic tests and therapies for these diseases.
The discovery and characterization of SEMA3B as a potential drug target and biomarker has the potential to have a significant impact on the treatment of various diseases. Further research is needed to fully understand the mechanism of SEMA3B's activity and its potential as a drug target and biomarker.
Overall, SEMA3B is a protein that has the potential to be a drug target and biomarker. Further research is needed to fully understand its mechanism of action and its potential as a therapeutic agent.
Protein Name: Semaphorin 3B
Functions: Inhibits axonal extension by providing local signals to specify territories inaccessible for growing axons
The "SEMA3B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEMA3B comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
SEMA3B-AS1 | SEMA3C | SEMA3D | SEMA3E | SEMA3F | SEMA3G | SEMA4A | SEMA4B | SEMA4C | SEMA4D | SEMA4F | SEMA4G | SEMA5A | SEMA5A-AS1 | SEMA5B | SEMA6A | SEMA6A-AS1 | SEMA6A-AS2 | SEMA6B | SEMA6C | SEMA6D | SEMA7A | Semenogelin | SEMG1 | SEMG2 | SENCR | SENP1 | SENP2 | SENP3 | SENP3-associated complex | SENP3-EIF4A1 | SENP5 | SENP6 | SENP7 | SENP8 | SEPHS1 | SEPHS1P4 | SEPHS1P6 | SEPHS2 | SEPSECS | SEPSECS-AS1 | SEPT5-GP1BB | SEPTIN1 | SEPTIN10 | SEPTIN11 | SEPTIN12 | SEPTIN14 | SEPTIN2 | SEPTIN3 | SEPTIN4 | SEPTIN4-AS1 | SEPTIN5 | SEPTIN6 | SEPTIN7 | SEPTIN7-DT | SEPTIN7P11 | SEPTIN7P14 | SEPTIN7P2 | SEPTIN7P6 | SEPTIN7P9 | SEPTIN8 | SEPTIN9 | SERAC1 | SERBP1 | SERBP1P3 | SERF1A | SERF1B | SERF2 | SERF2-C15ORF63 | SERGEF | SERHL | SERINC1 | SERINC2 | SERINC3 | SERINC4 | SERINC5 | Serine (or cysteine) proteinase inhibitor clade F | Serine palmitoyltransferase | Serine protease | Serine protease inhibitor | Serine-aspartate repeat-containing protein I-like | SERP1 | SERP2 | SERPINA1 | SERPINA10 | SERPINA11 | SERPINA12 | SERPINA13P | SERPINA2 | SERPINA3 | SERPINA4 | SERPINA5 | SERPINA6 | SERPINA7 | SERPINA9 | SERPINB1 | SERPINB10 | SERPINB11 | SERPINB12 | SERPINB13